Ecolab boosts earnings despite sales decline of 5 percent
Unlike many of its peers in the manufacturing sector, Ecolab avoided a double-digit revenue decline in the third quarter but CEO Doug Baker said Tuesday that's he's expecting a tough sales climate to continue.
"We aren't planning on any big boomerang effect next year, or big spike up in demand," Baker told analysts.
Sales at the St. Paul-based maker of cleaning and sanitizing products dropped 5 percent to $1.5 billion in the quarter as its profit rose 15 percent to $145 million.
Driven by sales growth of its health care products, Ecolab boosted its third-quarter earnings to 60 cents a share -- a 20 percent increase that was in line with analysts' expectations.
Ecolab's hand sanitizers have been popular in the fight against the H1N1 flu, and Baker said that H1N1-related products probably boosted third-quarter revenue by $10 million. He estimated that flu-related sales could increase revenue by $20 million in the fourth quarter.
In the United States, Ecolab sales slipped 1 percent in the third quarter and foreign exchange rates had a 5 percent negative effect on the company's overall sales. At local currency rates, Ecolab's sales rose 8 percent in Latin America, 2 percent in the Asia Pacific region, but declined 1 percent in Europe, the Middle East and Africa.
Ecolab on Tuesday narrowed its forecast for full-year earnings to $1.98 to $2.01 per share, a change from the $1.96 to $2.02 range released last quarter.
The company's stock closed Tuesday at $44.95 per share, down 2.1 percent.
Liz Fedor • 612-673-7709
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments